Historique
Bulletin de Périodique
International Journal of Drug Policy , Vol.100 - February 2022
Paru le :
01/02/2022
Année
2022
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- Comparing characteristics and outcomes of different opioid agonist treatment modalities among opioid-dependent federal men correctional populations in Canada. Farrell MacDonald S., Russell C., Beauchamp T., Derkzen D., Fischer B., art. 103480.
- More than saving lives: Qualitative findings of the UNODC/WHO Stop Overdose Safely (S-O-S) project. Walker S., Dietze P., Poznyak V., Campello G., Kashino W., Dzhonbekov D., et al., art. 103482.
- Warrant checking practices by post-overdose outreach programs in Massachusetts: A mixed-methods study. Tori M.E., Cummins E., Beletsky L., Schoenberger S.F., Lambert A.M., Yan S., et al., art. 103483.
- Privileged background protects against drug charges: A long-term population-based longitudinal study. Pedersen W., Moffitt T.E., von Soest T., art. 103491.
- Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence. Farrell M., Shahbazi J., Byrne M., Grebely J., Lintzeris N., Chambers M., et al., art. 103492.
- Cannabis adulterated with the synthetic cannabinoid receptor agonist MDMB-4en-PINACA and the role of European drug checking services. Oomen P.E., Schori D., Tögel-Lins K., Acreman D., Chenorhokian S., Luf A., et al., art. 103493.
- Trends in the sequence of initiation of alcohol, tobacco, and marijuana use among adolescents in Argentina and Chile from 2001 to 2017. Schleimer J.P., Smith N., Zaninovic V., Keyes K.M., Castillo-Carniglia A., Rivera-Aguirre A., et al., art. 103494.
- Association of medical cannabis licensure with prescription opioid receipt: A population-based, individual-level retrospective cohort study. Goedel W.C., Macmadu A., Shihipar A., Moyo P., Cerda M., Marshall B.D.L., art. 103502.
- Correlates of days of medication for opioid use disorder exposure among people living with HIV in Northern Vietnam. Button D., Cook R., King C., Khuyen T.T., Kunkel L., Bart G., et al., art. 103503.
- Assessing open science and citizen science in addictions and substance use research: A scoping review. Scheibein F., Donnelly W., Wells J.S.G., art. 103505.
- An examination of the role of changes in country-level leisure time internet use and computer gaming on adolescent drinking in 33 European countries. Vashishtha R., Holmes J., Pennay A., Dietze P.M., Livingston M., art. 103508.
- From the clinic to the street: the changing role of benzodiazepines in the Scottish overdose epidemic. McAuley A., Matheson C., Robertson J.R., art. 103512.
- Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a 'moral hazard' associated with naloxone supply. Tse W.C., Djordjevic F., Borja V., Picco L., Lam T., Olsen A., et al., art. 103513.
- Digital localisation in an illicit market space: interactional creation of a psychedelic assemblage in a darknet community of exchange. Sawicka M., Rafanell I., Bancroft A., art. 103514.
- 'Keeping a lid on it': Exploring 'problematisations' of prescribed medication in prisons in the UK. Duke K., Trebilcock J., art. 103515.
- Alcohol and tobacco consumption among Australian sexual minority women: Patterns of use and service engagement. Amos N., Bourne A., Hill A.O., Power J., McNair R., Mooney-Somers J., et al., art. 103516.
- Trends in cannabis use among U.S. adults amid the COVID-19 pandemic. Brenneke S.G., Nordeck C.D., Riehm K.E., Schmid I., Tormohlen K.N., Smail E.J., et al., art. 103517.
- Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting. Argento E., Socias M.E., Hayashi K., Choi J., Mackay L., Christie D., et al., art. 103518.
- Alarming increase in poisonings from recreational nitrous oxide use after a change in EU-legislation, inquiries to the Dutch Poisons Information Center. van Riel A.J.H.P., Hunault C.C., van den Hengel-Koot I.S., Nugteren-van Lonkhuyzen J.J., de Lange D.W., Hondebrink L., art. 103519.
- Reports of accidental fentanyl overdose among police in the field: Toward correcting a harmful culture-bound syndrome. del Pozo B., Rich J.D., Carroll J.J., art. 103520.
- Experiences with the Philadelphia police assisted diversion program: A qualitative study. Anderson E., Shefner R., Koppel R., Megerian C., Frasso R., art. 103521.
- Addressing the complex substance use and mental health needs of people leaving prison: Insights from developing a national inventory of services in Canada. Watson T.M., Benassi P.V., Agic B., Maharaj A., Sockalingam S., art. 103523.
- Motivational Interviewing-based interventions for reducing substance misuse and increasing treatment engagement, retention, and completion in the homeless populations of high-income countries: An equity-focused systematic review and narrative synthesis. Orciari E.A., Perman-Howe P.R., Foxcroft D.R., art. 103524.
- Simulating the impact of Addiction Consult Services in the context of drug supply contamination, hospitalizations, and drug-related mortality. King C.A., Cook R., Wheelock H., Korthuis P.T., Leahy J.M., Goff A., et al., art. 103525.
- Non-prescription drug use among HIV positive gay and bisexual men in Australia: A latent class analysis and comparison of health and well-being. Norman T., Bourne A., Power J., Meléndez-Torres G.J., art. 103526.
- Effects of recreational marijuana legalization on clearance rates for violent crimes: Evidence from Oregon. Wu G., Li Y., Lang X., art. 103528.
- Public health risks associated with methadone in Iran: A systematic review and meta-analysis. Rostam-Abadi Y., Gholami J., Noroozi A., Ansari M., Baheshmat S., Hamzehzadeh M., et al., art. 103529.
- Repeal of state laws permitting denial of health claims resulting from alcohol impairment: Impact on treatment utilization. Azagba S., Shan L., Hall M., Wolfson M., Chaloupka F., art. 103530.
- Are recreational cannabis laws associated with declining medical cannabis program enrollment in the U.S.? An analysis of cardholder enrollment and demographic characteristics from 2013 to 2020. Okey S.A., Castro S.A., Waddell J.T., Jones C.B., Blake A.J., O'Rourke H.P., et al., art. 103531.
- Factors associated with opioid-involved overdose among previously incarcerated people in the U.S.: A community engaged narrative review. Flam-Ross J.M., Lown J., Patil P., White L.F., Wang J., Perry A., et al., art. 103534.
- Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison. Curtis M., Berk J., Larney S., Rich J.D., Stoové M., art. 103572.
- Comparing characteristics and outcomes of different opioid agonist treatment modalities among opioid-dependent federal men correctional populations in Canada. Farrell MacDonald S., Russell C., Beauchamp T., Derkzen D., Fischer B., art. 103480.
- More than saving lives: Qualitative findings of the UNODC/WHO Stop Overdose Safely (S-O-S) project. Walker S., Dietze P., Poznyak V., Campello G., Kashino W., Dzhonbekov D., et al., art. 103482.
- Warrant checking practices by post-overdose outreach programs in Massachusetts: A mixed-methods study. Tori M.E., Cummins E., Beletsky L., Schoenberger S.F., Lambert A.M., Yan S., et al., art. 103483.
- Privileged background protects against drug charges: A long-term population-based longitudinal study. Pedersen W., Moffitt T.E., von Soest T., art. 103491.
- Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence. Farrell M., Shahbazi J., Byrne M., Grebely J., Lintzeris N., Chambers M., et al., art. 103492.
- Cannabis adulterated with the synthetic cannabinoid receptor agonist MDMB-4en-PINACA and the role of European drug checking services. Oomen P.E., Schori D., Tögel-Lins K., Acreman D., Chenorhokian S., Luf A., et al., art. 103493.
- Trends in the sequence of initiation of alcohol, tobacco, and marijuana use among adolescents in Argentina and Chile from 2001 to 2017. Schleimer J.P., Smith N., Zaninovic V., Keyes K.M., Castillo-Carniglia A., Rivera-Aguirre A., et al., art. 103494.
- Association of medical cannabis licensure with prescription opioid receipt: A population-based, individual-level retrospective cohort study. Goedel W.C., Macmadu A., Shihipar A., Moyo P., Cerda M., Marshall B.D.L., art. 103502.
- Correlates of days of medication for opioid use disorder exposure among people living with HIV in Northern Vietnam. Button D., Cook R., King C., Khuyen T.T., Kunkel L., Bart G., et al., art. 103503.
- Assessing open science and citizen science in addictions and substance use research: A scoping review. Scheibein F., Donnelly W., Wells J.S.G., art. 103505.
- An examination of the role of changes in country-level leisure time internet use and computer gaming on adolescent drinking in 33 European countries. Vashishtha R., Holmes J., Pennay A., Dietze P.M., Livingston M., art. 103508.
- From the clinic to the street: the changing role of benzodiazepines in the Scottish overdose epidemic. McAuley A., Matheson C., Robertson J.R., art. 103512.
- Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a 'moral hazard' associated with naloxone supply. Tse W.C., Djordjevic F., Borja V., Picco L., Lam T., Olsen A., et al., art. 103513.
- Digital localisation in an illicit market space: interactional creation of a psychedelic assemblage in a darknet community of exchange. Sawicka M., Rafanell I., Bancroft A., art. 103514.
- 'Keeping a lid on it': Exploring 'problematisations' of prescribed medication in prisons in the UK. Duke K., Trebilcock J., art. 103515.
- Alcohol and tobacco consumption among Australian sexual minority women: Patterns of use and service engagement. Amos N., Bourne A., Hill A.O., Power J., McNair R., Mooney-Somers J., et al., art. 103516.
- Trends in cannabis use among U.S. adults amid the COVID-19 pandemic. Brenneke S.G., Nordeck C.D., Riehm K.E., Schmid I., Tormohlen K.N., Smail E.J., et al., art. 103517.
- Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting. Argento E., Socias M.E., Hayashi K., Choi J., Mackay L., Christie D., et al., art. 103518.
- Alarming increase in poisonings from recreational nitrous oxide use after a change in EU-legislation, inquiries to the Dutch Poisons Information Center. van Riel A.J.H.P., Hunault C.C., van den Hengel-Koot I.S., Nugteren-van Lonkhuyzen J.J., de Lange D.W., Hondebrink L., art. 103519.
- Reports of accidental fentanyl overdose among police in the field: Toward correcting a harmful culture-bound syndrome. del Pozo B., Rich J.D., Carroll J.J., art. 103520.
- Experiences with the Philadelphia police assisted diversion program: A qualitative study. Anderson E., Shefner R., Koppel R., Megerian C., Frasso R., art. 103521.
- Addressing the complex substance use and mental health needs of people leaving prison: Insights from developing a national inventory of services in Canada. Watson T.M., Benassi P.V., Agic B., Maharaj A., Sockalingam S., art. 103523.
- Motivational Interviewing-based interventions for reducing substance misuse and increasing treatment engagement, retention, and completion in the homeless populations of high-income countries: An equity-focused systematic review and narrative synthesis. Orciari E.A., Perman-Howe P.R., Foxcroft D.R., art. 103524.
- Simulating the impact of Addiction Consult Services in the context of drug supply contamination, hospitalizations, and drug-related mortality. King C.A., Cook R., Wheelock H., Korthuis P.T., Leahy J.M., Goff A., et al., art. 103525.
- Non-prescription drug use among HIV positive gay and bisexual men in Australia: A latent class analysis and comparison of health and well-being. Norman T., Bourne A., Power J., Meléndez-Torres G.J., art. 103526.
- Effects of recreational marijuana legalization on clearance rates for violent crimes: Evidence from Oregon. Wu G., Li Y., Lang X., art. 103528.
- Public health risks associated with methadone in Iran: A systematic review and meta-analysis. Rostam-Abadi Y., Gholami J., Noroozi A., Ansari M., Baheshmat S., Hamzehzadeh M., et al., art. 103529.
- Repeal of state laws permitting denial of health claims resulting from alcohol impairment: Impact on treatment utilization. Azagba S., Shan L., Hall M., Wolfson M., Chaloupka F., art. 103530.
- Are recreational cannabis laws associated with declining medical cannabis program enrollment in the U.S.? An analysis of cardholder enrollment and demographic characteristics from 2013 to 2020. Okey S.A., Castro S.A., Waddell J.T., Jones C.B., Blake A.J., O'Rourke H.P., et al., art. 103531.
- Factors associated with opioid-involved overdose among previously incarcerated people in the U.S.: A community engaged narrative review. Flam-Ross J.M., Lown J., Patil P., White L.F., Wang J., Perry A., et al., art. 103534.
- Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison. Curtis M., Berk J., Larney S., Rich J.D., Stoové M., art. 103572.
Cote :
Abonnement
Dépouillements
Ajouter le résultat à votre sélection
P. E. OOMEN ;
D. SCHORI ;
K. TOGEL-LINS ;
D. ACREMAN ;
S. CHENORHOKIAN ;
A. LUF ;
A. KARDEN ;
C. PAULOS ;
E. FORNERO ;
E. GERACE ;
R. P. J. KONING ;
L. GALINDO ;
L. A. SMIT-RIGTER ;
F. MEASHAM ;
M. VENTURA
|
2022
Dans International Journal of Drug Policy (Vol.100, February 2022) Article : Périodique
Dans International Journal of Drug Policy (Vol.100, February 2022) Article : Périodique
Background: European drug checking services exchange information on drug trends within the Trans European Drug Information (TEDI) network, allowing monitoring and coordination of responses. Starting in Spring 2020, several services detected the [...]